153 related articles for article (PubMed ID: 7372439)
1. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
Noland JL; Amin M
Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen therapy on metastatic carcinoma of the prostate.
Anikwe RM
Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
[TBL] [Abstract][Full Text] [Related]
3. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
Hájek J; Hanselová M; Vrubel F
Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
[No Abstract] [Full Text] [Related]
4. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
5. [Contribution on the clinical aspects of prostatic carcinoma].
Sladczyk E
Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
[No Abstract] [Full Text] [Related]
6. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
[TBL] [Abstract][Full Text] [Related]
7. [Demonstration of specific antibodies against diethylstilbestrol during treatment of prostatic cancer].
Lille P; Abbou CC; Beaumont V; Chopin D; Bottine Y; Auvert J
Ann Urol (Paris); 1986; 20(2):113-6. PubMed ID: 3717898
[TBL] [Abstract][Full Text] [Related]
8. [High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma].
Kattan J; Droz JP; Culine S
Bull Cancer; 1993 Mar; 80(3):248-54. PubMed ID: 8173177
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
Fraley EE; Paulson DF
Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
[No Abstract] [Full Text] [Related]
10. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
Hellerstedt B; Pienta KJ; Redman BG; Esper P; Dunn R; Fardig J; Olson K; Smith DC
Cancer; 2003 Oct; 98(8):1603-10. PubMed ID: 14534875
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
14. [Plasma concentrations of fosfestrol as well as diethylstilbestrol on their conjugates following intravenous administration on prostatic carcinoma patients].
Oelschläger H; Rothley D; Dunzendorfer U
Arzneimittelforschung; 1986 Aug; 36(8):1284-9. PubMed ID: 3778569
[TBL] [Abstract][Full Text] [Related]
15. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
[TBL] [Abstract][Full Text] [Related]
16. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
[TBL] [Abstract][Full Text] [Related]
17. [Study on prevention of flare-up phenomenon following initial LH-RH analogue administration: combination therapy with diethylstilbestrol].
Takeuchi S; Yoshida K; Tosaka A; Kobayashi N; Higashi Y; Negishi T
Hinyokika Kiyo; 1995 Mar; 41(3):191-6. PubMed ID: 7741071
[TBL] [Abstract][Full Text] [Related]
18. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
Ushiyama T; Ihara H; Kurita Y; Kageyama S; Ueda D; Mugiya S; Yamaguchi Y; Nakano M; Suzuki K; Kawabe K
Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
Isurugi K
Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
[TBL] [Abstract][Full Text] [Related]
20. [Anti-androgenic therapy for prostate carcinoma].
Schoonees R
S Afr Med J; 1973 May; 47(17):722-4. PubMed ID: 4702294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
